Search

Your search keyword '"Zdrojowy, Romuald"' showing total 313 results
Start Over Author "Zdrojowy, Romuald"
313 results on '"Zdrojowy, Romuald"'

1. Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

Author

Mastroianni, Riccardo, Brassetti, Ado, Krajewski, Wojciech, Zdrojowy, Romuald, Salhi, Yazan Al, Anceschi, Umberto, Bove, Alfredo Maria, Carbone, Antonio, De Nunzio, Cosimo, Fuschi, Andrea, Ferriero, Mariaconsiglia, Nacchia, Antonio, Pastore, Antonio Luigi, Tema, Giorgia, Tuderti, Gabriele, Gallucci, Michele, and Simone, Giuseppe

Published
2021
Full Text
View/download PDF

5. Influence of Transurethral Resection of Bladder Cancer on Sexual Function, Anxiety, and Depression

Author

Krajewski, Wojciech, Halska, Urszula, Poletajew, Sławomir, Piszczek, Radosław, Bieżyński, Bartosz, Matyjasek, Mateusz, Tukiendorf, Andrzej, Menzel, Fryderyk, Mazur, Małgorzata, Rymaszewska, Joanna, Zdrojowy, Romuald, COHEN, IRUN R., Series Editor, LAJTHA, ABEL, Series Editor, LAMBRIS, JOHN D., Series Editor, PAOLETTI, RODOLFO, Series Editor, Rezaei, Nima, Series Editor, and Pokorski, Mieczyslaw, editor

Published
2018
Full Text
View/download PDF

9. Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma -- results of a prospective cohort study.

Author

Tupikowski, Krzysztof, Partyka, Anna, Pawlak, Edyta A., Ptaszkowski, Kuba, Zdrojowy, Romuald, Frydecka, Irena, Hałoń, Agnieszka, and Karabon, Lidia

Subjects
RENAL cell carcinoma, OVERALL survival, SINGLE nucleotide polymorphisms, GENETIC variation, IMMUNE checkpoint proteins, PROGRAMMED cell death 1 receptors
Abstract

Introduction: The successful introduction of immune checkpoint blockade approaches to renal-cell carcinoma (RCC) treatment indicates the importance of molecules regulating the T cell response to RCC risk and progression. Material and methods: In this study, we evaluate the association of variations in the CTLA-4, BTLA and CD28 genes with overall survival (OS) of RCC patients and specifically clear cell RCC (ccRCC) patients. The following single nucleotide polymorphisms (SNPs) previously genotyped using the RFLP method or TaqMan SNP Genotyping Assays were analyzed: CTLA-4 gene: c.49A>G (rs231775), g.319C>T (rs5742909), g.*6230G>A (CT60; rs3087243), g.*10223G>T (Jo31; rs11571302); CD28 gene: c.17+3T>C (rs3116496), c.-1042G>A (rs3181098); BTLA gene: rs2705511, rs1982809, rs9288952, rs9288953, rs2705535 and rs1844089. Results: During long term observation (6.5 years) we discovered that possessing the A allele at BTLA rs1844089 SNP, together with advanced disease (stage ≥ 3, tumor grade > 3, tumor diameter ≥ 70 mm), is an independent risk factor of death which increases the hazard ratio (HR) of death by more than two-fold (HR = 2.21, 95% CI: 1.28--3.83). Furthermore, the OS of patients bearing this allele is 6 months shorter than for homozygous (GG) patients (42.5 vs. 48.2 months). Conclusions: Our results indicate for the first time that genetic variation within the gene encoding BTLA is significantly associated with overall survival in clear cell renal cell carcinoma patients. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

Author

Polish Hereditary Prostate Cancer Consortium, Antczak, Andrzej, Wokołorczyk, Dominika, Kluźniak, Wojciech, Kashyap, Aniruddh, Jakubowska, Anna, Gronwald, Jacek, Huzarski, Tomasz, Byrski, Tomasz, Dębniak, Tadeusz, Masojć, Bartłomiej, Górski, Bohdan, Gromowski, Tomasz, Gołąb, Adam, Sikorski, Andrzej, Słojewski, Marcin, Gliniewicz, Bartłomiej, Borkowski, Tomasz, Borkowski, Andrzej, Przybyła, Jacek, Sosnowski, Marek, Małkiewicz, Bartosz, Zdrojowy, Romuald, Sikorska-Radek, Paulina, Matych, Józef, Wilkosz, Jacek, Różański, Waldemar, Kiś, Jacek, Bar, Krzysztof, Janiszewska, Hanna, Stawicka, Małgorzata, Milecki, Piotr, Lubiński, Jan, Narod, Steven A., and Cybulski, Cezary

Published
2015

11. Laparoscopic Living Donor Nephrectomy—Single-Center Initial Experience

Author

Małkiewicz, Bartosz, primary, Kamińska, Dorota, additional, Kobylański, Maximilian, additional, Łątkowska, Małgorzata, additional, Handzlik, Wojciech, additional, Dębiński, Paweł, additional, Krajewski, Wojciech, additional, Mazanowska, Oktawia, additional, Poznański, Paweł, additional, Banasik, Mirosław, additional, Patrzałek, Dariusz, additional, Janczak, Dariusz, additional, Krajewska, Magdalena, additional, Zdrojowy, Romuald, additional, and Szydełko, Tomasz, additional

Published
2022
Full Text
View/download PDF

12. The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors - a prospective study.

Author

Tupikowski, Krzysztof, Jaobsche-Policht, Urszula, Bittner, Jadwiga, Ptaszkowski, Kuba, Halon, Agnieszka, Zdrojowy, Romuald, Adamiec, Rajmund, and Gosk-Bierska, Izabela

Subjects
KIDNEY tumors, FIBRINOLYSIS, OVERALL survival, VON Willebrand factor, VOLUNTEER recruitment, KIDNEY transplantation
Abstract

Introduction: Multiple studies suggest that cancer leads to activation of clotting and fibrinolysis pathways, elevating the risk of thromboembolic events. Kidney cancer is often complicated by clotting disorders. In this study, we hypothesized that preoperative clotting and fibrinolysis parameters are altered in healthy volunteers and kidney tumor patients. We also hypothesized that these differences may be associated with survival in patients who have undergone operations due to kidney tumors. Material and methods: In this study, 96 patients with kidney tumors and 30 healthy volunteers were recruited at a single university center. All patients were assessed for pre-operative serum concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI, total TFPI, full-length TFPI, truncated TFPI), plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), von Willebrand factor (vWF), clotting factor XIII A1 (FXIIIA1), D-dimers, and fibrinogen. Additionally, standard peripheral blood morphology was evaluated. Results: Malignant kidney tumors were diagnosed in 85 of 96 tumor patients. In patients with kidney tumors, there were statistically significantly higher concentrations of fibrinogen, D-dimers, TAT, PAF, TF, TFPI, vWF, FXIIIA1, and leukocyte counts compared to the control group. Statistically significant correlations were found between multiple parameters. This points to significant clotting system alterations. Cox stepwise hazard analysis showed that pre-operative fibrinogen and D-Dimer concentrations were significantly associated with survival. Conclusions: In patients with kidney tumors, multiple clotting and fibrinolysis parameters are significantly altered. Routine pre-operative measures should include determination of fibrinogen and D-dimer concentrations as these markers aid in prediction of survival probability. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

14. Methods of coping with neoplastic disease in men with non‐muscle‐invasive bladder cancer.

Author

Mazur, Małgorzata, Chorbińska, Joanna, Nowak, Łukasz, Halska, Urszula, Bańkowska, Kinga, Sójka, Aleksandra, Małkiewicz, Bartosz, Zdrojowy, Romuald, Pałęga, Anna, Szydełko, Tomasz, and Krajewski, Wojciech

Subjects
PREVENTION of mental depression, ANXIETY prevention, PREVENTION of psychological stress, PUBLIC health surveillance, ONCOLOGY nursing, STATISTICS, MEN'S health, TRANSURETHRAL prostatectomy, CONFIDENCE intervals, CARCINOGENESIS, CYSTOSCOPY, MENTAL health, MANN Whitney U Test, NON-muscle invasive bladder cancer, ATTITUDES toward illness, QUESTIONNAIRES, NURSING research, CHI-squared test, FACTOR analysis, PSYCHOLOGICAL adaptation, SEXUAL excitement, SOCIODEMOGRAPHIC factors, ODDS ratio, DATA analysis, LOGISTIC regression analysis, LONGITUDINAL method
Abstract

Only limited data evaluating coping methods in patients with bladder cancer are available in the literature. Also, it is unclear how the mental status of these patients affects their stress coping strategies. The aim of the study was to evaluate the stress coping strategies in patients with non‐muscle‐invasive bladder cancer (NMIBC) and to assess the impact of sociodemographic factors, presence of anxiety and depressive symptoms and degree of sexual satisfaction on stress coping strategies. This prospective cohort study included 100 male patients qualified for control cystoscopy who underwent at least one transurethral resection of bladder tumour (TURB) procedure in the past for NMIBC and at least one control cystoscopy. The minimal follow‐up period after primary TURB was 1 year. The MiniCOPE, the Hospital Anxiety and Depression Scale and the Sexual Satisfaction Questionnaire were used. The questionnaires were completed anonymously before cystoscopy in a room that provided privacy. Majority patients with NMIBC chosen adaptive strategies, with 'accepting' and 'seeking emotional support' being the most common. The choice of strategy was influenced by the severity of anxiety and depressive symptoms as well as the level of sexual satisfaction and pain sensations. Also, sociodemographic variables, such as marriage status, progeniture or the level of education played a role in strategy selection. The results of this study indicate that patients with NMIBC choose adaptive stress coping strategies. It also provides a better understanding of the impact of various aspects of mental health in patients with NMIBC on coping with stress. Each patient treated for NMIBC should undergo appropriate psychological and sociodemographic evaluation, which will allow easier identification of patients at high risk of treatment and postoperative surveillance discontinuation. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

15. Influence of Virtual Reality Devices on Pain and Anxiety in Patients Undergoing Cystoscopy Performed under Local Anaesthesia

Author

Łuczak, Mateusz, primary, Nowak, Łukasz, additional, Chorbińska, Joanna, additional, Galik, Katarzyna, additional, Kiełb, Paweł, additional, Łaszkiewicz, Jan, additional, Tukiendorf, Andrzej, additional, Kościelska-Kasprzak, Katarzyna, additional, Małkiewicz, Bartosz, additional, Zdrojowy, Romuald, additional, Szydełko, Tomasz, additional, and Krajewski, Wojciech, additional

Published
2021
Full Text
View/download PDF

17. External validation of the Briganti nomogram to predict lymph node invasion in prostate cancer - setting a new threshold value

Author

Małkiewicz, Bartosz, Ptaszkowski, Kuba, Knecht, Klaudia, Gurwin, Adam, Wilk, Karol, Kiełb, Paweł, Dudek, Krzysztof, and Zdrojowy, Romuald

Subjects
urologic and male genital diseases, urology
Abstract

Introduction: The aim of the study was to test and validate the performance of the 2012 Briganti nomogram as a predictor for pelvic lymph node invasion (LNI) in men who underwent radical prostatectomy (RP) with extended pelvic lymph node dissection (PLND), to examine their performance and to analyse the therapeutic impact of using different nomogram cut-off . Material and methods: The study group consisted of 222 men with clinically localized prostate cancer (PCa) who underwent RP with ePLND between 01/2012 and 10/2018. Measurements included: preoperative PSA, clinical stage (CS), primary and secondary biopsy Gleason pattern and percentage of positive cores. The area under curve (AUC) of the receiver operator characteristic analysis was appointed to quantify accuracy of the primary nomogram model to predict LNI. The extent of estimation associated with the use of this model was graphically depicted using calibration plots. Results: The median number of removed lymph nodes was 16 (IQR 12-21). A total of 53 of 222 patients (23,9%) had LNI. Preoperative clinical and biopsy characteristics differed significantly (all p

Published
2021

23. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy : Systematic Review and Meta-Analysis

Author

Krajewski, Wojciech, Nowak, Łukasz, Moschini, Marco, Poletajew, Sławomir, Chorbińska, Joanna, Necchi, Andrea, Montorsi, Francesco, Briganti, Alberto, Sanchez-Salas, Rafael, Shariat, Shahrokh F, Palou, Juan, Babjuk, Marek, Teoh, Jeremy YC, Soria, Francesco, Pradere, Benjamin, Ornaghi, Paola Irene, Pawlak, Aleksandra, Dembowski, Janusz, Zdrojowy, Romuald, Universitat Autònoma de Barcelona, Krajewski, Wojciech, Nowak, Łukasz, Moschini, Marco, Poletajew, Sławomir, Chorbińska, Joanna, Necchi, Andrea, Montorsi, Francesco, Briganti, Alberto, Sanchez-Salas, Rafael, Shariat, Shahrokh F, Palou, Juan, Babjuk, Marek, Teoh, Jeremy YC, Soria, Francesco, Pradere, Benjamin, Ornaghi, Paola Irene, Pawlak, Aleksandra, Dembowski, Janusz, Zdrojowy, Romuald, and Universitat Autònoma de Barcelona

Abstract

Background: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) with pelvic lymph-node dissection is the standard treatment for cT2-4a cN0 cM0 muscle-invasive bladder cancer (MIBC). Despite the significant improvement of primary-tumor downstaging with NAC, up to 50% of patients are eventually found to have advanced residual disease (pT3-T4 and/or histopathologically confirmed nodal metastases (pN+)) at RC. Currently, there is no established standard of care in such cases. The aim of this systematic review and meta-analysis was to assess differences in survival rates between patients with pT3-T4 and/or pN+ MIBC who received NAC and surgery followed by adjuvant chemotherapy (AC), and patients without AC. Materials and Methods: A systematic search was conducted in accordance with the PRISMA statement using the Medline, Embase, and Cochrane Library databases. The last search was performed on 12 November 2020. The primary end point was overall survival (OS) and the secondary end point was disease-specific survival (DSS). Results: We identified 2124 articles, of which 6 were selected for qualitative and quantitative analyses. Of a total of 3096 participants in the included articles, 2355 (76.1%) were in the surveillance group and 741 (23.9%) received AC. The use of AC was associated with significantly better OS (hazard ratio (HR) 0.84, 95% confidence interval (CI) 0.75-0.94; p = 0.002) and DSS (HR 0.56, 95% CI 0.32-0.99; p = 0.05). Contrary to the main analysis, in the subgroup analysis including only patients with pN+, AC was not significantly associated with better OS compared to the surveillance group (HR 0.89, 95% CI 0.58-1.35; p = 0.58). Conclusions: The administration of AC in patients with MIBC and pT3-T4 residual disease after NAC might have a positive impact on OS and DSS. However, this may not apply to N+ patients.

Published
2021

24. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Author

Walter, Steffen, Weinschenk, Toni, Stenzl, Arnulf, Zdrojowy, Romuald, Pluzanska, Anna, Szczylik, Cezary, Staehler, Michael, Brugger, Wolfram, Dietrich, Pierre-Yves, Mendrzyk, Regina, Hilf, Norbert, Schoor, Oliver, Fritsche, Jens, Mahr, Andrea, Maurer, Dominik, Vass, Verona, Trautwein, Claudia, Lewandrowski, Peter, Flohr, Christian, Pohla, Heike, Stanczak, Janusz J., Bronte, Vincenzo, Mandruzzato, Susanna, Biedermann, Tilo, Pawelec, Graham, Derhovanessian, Evelyna, Yamagishi, Hisakazu, Miki, Tsuneharu, Hongo, Fumiya, Takaha, Natsuki, Hirakawa, Kosei, Tanaka, Hiroaki, Stevanovic, Stefan, Frisch, Jurgen, Mayer-Mokler, Andrea, Kirner, Alexandra, Rammensee, Hans-Georg, Reinhardt, Carsten, and Singh-Jasuja, Harpreet

Subjects
Cyclophosphamide -- Dosage and administration, Polypeptides -- Health aspects, Immune response -- Research, Cancer vaccines -- Dosage and administration, Biological sciences, Health
Abstract

IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally presented in human cancer tissue. We treated a total of 96 human leukocyte antigen A (HLA-A)*02+ subjects with advanced RCC with IMA901 in two consecutive studies. In the phase 1 study, the T cell responses of the patients to multiple TUMAPs were associated with better disease control and lower numbers of prevaccine forkhead box P3 (FOXP3)+ regulatory T ([T.sub.reg]) cells. The randomized phase 2 trial showed that a single dose of cyclophosphamide reduced the number of [T.sub.reg] cells and confirmed that immune responses to multiple TUMAPs were associated with longer overall survival. Furthermore, among six predefined populations of myeloid-derived suppressor cells, two were prognostic for overall survival, and among over 300 serum biomarkers, we identified apolipoprotein A-I (APOA1) and chemokine (C-C motif) ligand 17 (CCL17) as being predictive for both immune response to IMA901 and overall survival. A randomized phase 3 study to determine the clinical benefit of treatment with IMA901 is ongoing., Therapeutic cancer vaccines hold the promise of combining meaningful efficacy (prolongation of survival) with very good safety and tolerability, as has been shown in several recent randomized trials. (1-3) However, [...]

Published
2012
Full Text
View/download PDF

25. Adult Wilms tumour

Author

Zdrojowy, Romuald, Sawicz-Birkowska, Krystyna, Apoznański, Wojciech, Patkowski, Dariusz, Szydełko, Tomasz, Pietras, Wojciech, and Dembowski, Janusz

Published
2011
Full Text
View/download PDF

26. The presence of prostate cancer at biopsy is predicted by a number of genetic variants

Author

Kashyap, Aniruddh, Kluźniak, Wojciech, Wokołorczyk, Dominika, Gołąb, Adam, Sikorski, Andrzej, Słojewski, Marcin, Gliniewicz, Bartłomiej, Świtała, Jerzy, Borkowski, Tomasz, Borkowski, Andrzej, Antczak, Andrzej, Wojnar, Łukasz, Przybyła, Jacek, Sosnowski, Marek, Małkiewicz, Bartosz, Zdrojowy, Romuald, Sikorska-Radek, Paulina, Matych, Józef, Wilkosz, Jacek, Różański, Waldemar, Kiś, Jacek, Bar, Krzysztof, Bryniarski, Piotr, Paradysz, Andrzej, Jersak, Konrad, Niemirowicz, Jerzy, Słupski, Piotr, Jarzemski, Piotr, Skrzypczyk, Michał, Dobruch, Jakub, Domagała, Paweł, Piotrowski, Krzysztof, Jakubowska, Anna, Gronwald, Jacek, Huzarski, Tomasz, Byrski, Tomasz, Dębniak, Tadeusz, Górski, Bohdan, Masojć, Bartłomiej, van de Wetering, Thierry, Menkiszak, Janusz, Akbari, Mohammad R., Lubiński, Jan, Narod, Steven A., and Cybulski, Cezary

Published
2014
Full Text
View/download PDF

30. Impact of Adjuvant Chemotherapy on Survival of Patients with Advanced Residual Disease at Radical Cystectomy following Neoadjuvant Chemotherapy: Systematic Review and Meta-Analysis

Author

Krajewski, Wojciech, primary, Nowak, Łukasz, additional, Moschini, Marco, additional, Poletajew, Sławomir, additional, Chorbińska, Joanna, additional, Necchi, Andrea, additional, Montorsi, Francesco, additional, Briganti, Alberto, additional, Sanchez-Salas, Rafael, additional, Shariat, Shahrokh F, additional, Palou, Juan, additional, Babjuk, Marek, additional, Teoh, Jeremy YC, additional, Soria, Francesco, additional, Pradere, Benjamin, additional, Ornaghi, Paola Irene, additional, Pawlak, Aleksandra, additional, Dembowski, Janusz, additional, and Zdrojowy, Romuald, additional

Published
2021
Full Text
View/download PDF

31. Not as black as it is painted? The impact of the first wave of COVID-19 pandemic on surgical treatment of urological cancer patients in Poland – a cross-country experience

Author

Zapała, Piotr, primary, Ślusarczyk, Aleksander, additional, Rajwa, Paweł, additional, Przydacz, Mikołaj, additional, Krajewski, Wojciech, additional, Dybowski, Bartosz, additional, Kubik, Przemysław, additional, Kuffel, Błażej, additional, Przudzik, Maciej, additional, Osiecki, Rafał, additional, Stamirowski, Remigiusz, additional, Zapała, Łukasz, additional, Kozikowski, Mieszko, additional, Chorągwicki, Dominik, additional, Szymańska, Magdalena, additional, Kiełb, Paweł, additional, Małkiewicz, Bartosz, additional, Zostawa, Jacek, additional, Roslan, Marek, additional, Zajączkowska, Joanna, additional, Jarzemski, Marcin, additional, Brzoszczyk, Bartosz, additional, Petrasz, Piotr, additional, Jarzemski, Piotr, additional, Zdrojowy, Romuald, additional, Dobruch, Jakub, additional, Paradysz, Andrzej, additional, Drewa, Tomasz, additional, Chłosta, Piotr, additional, and Radziszewski, Piotr, additional

Published
2021
Full Text
View/download PDF

34. En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study

Author

Poletajew, Sławomir, primary, Krajewski, Wojciech, additional, Stelmach, Paweł, additional, Adamowicz, Jan, additional, Nowak, Łukasz, additional, Moschini, Marco, additional, Zapała, Piotr, additional, Drewa, Tomasz, additional, Paradysz, Andrzej, additional, Radziszewski, Piotr, additional, Zdrojowy, Romuald, additional, and Kryst, Piotr, additional

Published
2021
Full Text
View/download PDF

38. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland

Author

Kluźniak, Wojciech, Wokołorczyk, Dominika, Kashyap, Aniruddh, Jakubowska, Anna, Gronwald, Jacek, Huzarski, Tomasz, Byrski, Tomasz, Dębniak, Tadeusz, Gołąb, Adam, Gliniewicz, Bartłomiej, Sikorski, Andrzej, Świtała, Jerzy, Borkowski, Tomasz, Borkowski, Andrzej, Antczak, Andrzej, Wojnar, Łukasz, Przybyła, Jacek, Sosnowski, Marek, Małkiewicz, Bartosz, Zdrojowy, Romuald, Sikorska-Radek, Paulina, Matych, Józef, Wilkosz, Jacek, Różański, Waldemar, Kiś, Jacek, Bar, Krzysztof, Bryniarski, Piotr, Paradysz, Andrzej, Jersak, Konrad, Niemirowicz, Jerzy, Słupski, Piotr, Jarzemski, Piotr, Skrzypczyk, Michał, Dobruch, Jakub, Domagała, Paweł, Akbari, Mohammad R., Lubiński, Jan, Narod, Steven A., and Cybulski, Cezary

Published
2013
Full Text
View/download PDF

39. Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic Benefit

Author

Krajewski, Wojciech, primary, Moschini, Marco, additional, Nowak, Łukasz, additional, Poletajew, Sławomir, additional, Tukiendorf, Andrzej, additional, Afferi, Luca, additional, Teoh, Jeremy, additional, Muilwijk, Tim, additional, Joniau, Steven, additional, Tafuri, Alessandro, additional, Antonelli, Alessandro, additional, Gozzo, Alessandra, additional, Mari, Andrea, additional, Di Trapani, Ettore, additional, Hendricksen, Kees, additional, Alvarez-Maestro, Mario, additional, Serrano, Andrea Rodriguez, additional, Simone, Giuseppe, additional, Zamboni, Stefania, additional, Simeone, Claudio, additional, Marconi, Maria Cristina, additional, Mastroianni, Riccardo, additional, Ploussard, Guillaume, additional, Rajwa, Paweł, additional, Laukhtina, Ekaterina, additional, Zdrojowy-Wełna, Aleksandra, additional, Kołodziej, Anna, additional, Paradysz, Andrzej, additional, Tully, Karl, additional, Krajewska, Joanna, additional, Piszczek, Radosław, additional, Xylinas, Evanguelos, additional, and Zdrojowy, Romuald, additional

Published
2020
Full Text
View/download PDF

42. Changing patterns of urologic emergency visits and admissions during the COVID-19 pandemic: a retrospective, multicenter, nationwide study

Author

Rajwa, Pawel, primary, Przydacz, Mikolaj, additional, Krajewski, Wojciech, additional, Kuffel, Blazej, additional, Zapala, Piotr, additional, Krzywon, Aleksandra, additional, Cortez, Alexander, additional, Dybowski, Bartosz, additional, Stamirowski, Remigiusz, additional, Jarzemski, Marcin, additional, Drobot, Rafal, additional, Stelmach, Pawel, additional, Mlynarek, Krystyna, additional, Marcinek, Mateusz, additional, Przudzik, Maciej, additional, Krawczyk, Wiktor, additional, Ryszawy, Jakub, additional, Choragwicki, Dominik, additional, Zapala, Lukasz, additional, Lipa, Marcin, additional, Pozniak, Michal, additional, Janczak, Dawid, additional, Słomian, Szymon, additional, Łaszkiewicz, Jan, additional, Nowak, Marcel, additional, Miszczyk, Marcin, additional, Roslan, Marek, additional, Tkocz, Michał, additional, Zdrojowy, Romuald, additional, Potyka, Andrzej, additional, Szydełko, Tomasz, additional, Drewa, Tomasz, additional, Jarzemski, Piotr, additional, Radziszewski, Piotr, additional, Slojewski, Marcin, additional, Antoniewicz, Artur, additional, Paradysz, Andrzej, additional, and Chlosta, Piotr L., additional

Published
2020
Full Text
View/download PDF

44. The Impact of Restaging Transurethral Resection of Bladder Tumor on Survival Parameters in T1 Nonmuscle-Invasive Bladder Cancer: Systematic Review and Meta-Analysis

Author

Krajewski, Wojciech, primary, Nowak, Łukasz, additional, Poletajew, Sławomir, additional, Tukiendorf, Andrzej, additional, Moschini, Marco, additional, Mari, Andrea, additional, Di Trapani, Ettore, additional, Xylinas, Evanguelos, additional, Kiełb, Paweł, additional, Wełna, Marek, additional, and Zdrojowy, Romuald, additional

Published
2020
Full Text
View/download PDF

50. Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour – a prospective multicentre observational study

Author

Poletajew, Sławomir, primary, Krajewski, Wojciech, additional, Gajewska, Dominika, additional, Sondka-Migdalska, Joanna, additional, Borowik, Michał, additional, Buraczyński, Paweł, additional, Dzięgała, Mateusz, additional, Łykowski, Marcin, additional, Przudzik, Maciej, additional, Tukiendorf, Andrzej, additional, Woźniak, Rafał, additional, Bar, Krzysztof, additional, Jabłonowski, Zbigniew, additional, Roslan, Marek, additional, Słojewski, Marcin, additional, Zdrojowy, Romuald, additional, Radziszewski, Piotr, additional, and Dziobek, Konrad, additional

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results